Related content

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Non-Receptor Tyrosine Kinase Fes in Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2913-2920

Bentham Science Publishers

Access to resources Recommend Favorite

The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1739-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Putting the Brakes on Cancer: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

By  

Pharmaceutical Innovation, Vol. 12, Iss. 1, 2002-12 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Tyrosine kinase receptor alteration of renal vasoconstriction in rats is sex- and age-related

By Fleming John T.   Tyagi Suresh C.   Falcone Jeff C.  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 10, 2012-10 ,pp. : 1372-1379

NRC Research Press

Access to resources Recommend Favorite